Andrius Žučenka: Congratulations to All the Investigators Involved in the PARADIGM trial
Andrius Žučenka, Assistant professor at Vilniaus universitetas / Vilnius University, shared a post on LinkedIn:
“First and foremost, huge congratulations to all the investigators and everyone involved in the Paradigm trial, the hottest acute myeloid leukemia (AML) topic at the American Society of Hematology 2025. King 7+3 took a massive blow. But has lord HMA+Ven truly won?
Before reading further I sincerely recommend listening to the most recent Wolverheme podcast.
Bernard Marini and Anthony Perissinotti superbly analyzed the presented abstract in such great detail, that there’s no point for me to go through specific trial data here, (KUDOS, guys). I want to simply present my few thoughts from a general/our center’s perspective.”
Read full paper here.
Get the latest updates on Hemostasis Today.
-
Mar 18, 2026, 16:34Richard Buka: Exploring the COBRRA Trial in the Latest Episode of Don’t Just Read the Abstract
-
Mar 18, 2026, 16:22Heghine Khachatryan: Navigating the New Era of Hemophilia Gene Therapy
-
Mar 18, 2026, 16:21Georges Chahoud: Top Take-Home Messages from the AHA/ACC/Multisociety Acute PE Guideline
-
Mar 18, 2026, 16:19Cedric Hermans: Unleashing the Potential of Physical Activity in Hemophilia A Patients
-
Mar 18, 2026, 16:17Asif Mushtaq: Managing Cardiac Surgery with Cardiopulmonary Bypass in Hemophilia
-
Mar 18, 2026, 16:15Amir Kraitzer: Engineering Hemocompatible Surfaces to Overcome Thrombosis in Medical Devices
-
Mar 18, 2026, 16:11Hemant Sharma: Advancing Neonatal Care with New Strategies to Prevent IVH
-
Mar 18, 2026, 16:09Yves Bikorimana: How a Simple Temperature Change Can Trigger Antibody-Mediated Destruction of RBCs
-
Mar 18, 2026, 16:07Scott Isaacs: Optimizing Brain Vitality and Slowing Neurodegeneration Through Daily Habits